Life360 Announces Pricing of U.S. Initial Public Offering
Life360, based in San Francisco, announced the pricing of its U.S. initial public offering (IPO) of 5,750,000 shares of common stock at $27.00 per share. Life360 is offering 3,703,704 shares, and selling securityholders are offering 2,046,296 shares. The company expects the shares to start trading on the Nasdaq under the ticker 'LIF' on June 6, 2024. The offering is anticipated to close on June 7, 2024. The underwriters have a 30-day option to purchase up to an additional 862,500 shares. Life360 aims to use the proceeds to enhance its capitalization, financial flexibility, and for general corporate purposes. Existing shares will continue trading on the Australian Securities Exchange as CHESS Depositary Interests (CDIs). The offering is managed by Goldman Sachs, Evercore ISI, UBS, and others.
- Initial public offering (IPO) pricing set at $27.00 per share.
- Expected to begin trading on Nasdaq under the ticker 'LIF'.
- Offering aims to increase company capitalization and financial flexibility.
- Net proceeds intended for general corporate purposes.
- Life360's shares will continue trading on the Australian Securities Exchange (ASX).
- Participation by major investment banks like Goldman Sachs, Evercore ISI, and UBS.
- Life360 will not receive proceeds from shares sold by selling securityholders.
- Potential dilution with an additional 862,500 shares option for underwriters.
Insights
The announcement of Life360's initial public offering (IPO) in the United States is significant for both the company and its potential investors. With an offering price of
The offering of 5,750,000 shares includes 3,703,704 shares from Life360 and 2,046,296 shares from selling securityholders, with an additional option of 862,500 shares for underwriters. It is worth noting that Life360 will not benefit from the shares sold by the securityholders.
From a financial perspective, this capital influx can bolster Life360’s balance sheet and provide more resources for operational and strategic initiatives. It is also a positive sign of confidence from major underwriters like Goldman Sachs, Evercore ISI and UBS Investment Bank.
The stock's performance post-IPO will be a key indicator of market sentiment and investor confidence in Life360's growth potential.
Life360's decision to launch an IPO in the U.S. reflects a broader strategy to increase market visibility and attract a diverse investor base. Listing on the Nasdaq Global Select Market provides enhanced liquidity and access to the deep pool of capital U.S. markets offer. This move also aligns with the company's growth ambitions, potentially leading to increased brand recognition and market share in the competitive landscape of family safety and location services.
However, investors should consider the inherent risks associated with IPOs, such as market volatility and the company's ability to meet its growth projections. The dual listing on the Australian Securities Exchange and Nasdaq might also introduce complexities in stock performance and valuation.
Overall, the IPO is a significant milestone for Life360, potentially paving the way for future growth and expansion.
Life360's IPO brings several corporate governance aspects into focus. The involvement of prominent underwriters ensures a level of due diligence and credibility, but investors should remain vigilant about the governance practices and transparency of the company. The fact that Life360 will not receive proceeds from shares sold by securityholders could raise questions about the motivations of existing shareholders.
This public offering also increases the company's obligations in terms of SEC reporting and compliance, which can be both an opportunity for improved governance and a challenge in terms of regulatory burden.
For retail investors, understanding these governance dynamics is essential for making informed investment decisions.
The Company intends to use the net proceeds it receives from the proposed offering to increase its capitalization and financial flexibility, to create a public market for its common stock in the United States and for general corporate purposes, including working capital, operating expenses and capital expenditures.
The Company, with headquarters in the San Francisco area and pre-existing SEC reporting obligations, views the Offering and increased exposure to U.S. investors as a natural next-step in its growth. The Company's CHESS Depositary Interests ("CDIs") (representing underlying shares of common stock on a 3 CDIs-for-1 share of common stock basis) will remain listed on the Australian Securities Exchange.
Goldman Sachs & Co. LLC, Evercore ISI and UBS Investment Bank are acting as joint book-running managers for the Offering. Stifel is acting as an additional book-running manager for the Offering. Canaccord Genuity, Citizens JMP and Loop Capital Markets are acting as co-managers for the Offering.
A registration statement on Form S-3 (Registration No. 333-279271) (including a base prospectus) has been filed with the SEC and became automatically effective on May 9, 2024. A preliminary prospectus supplement and accompanying prospectus relating to the Offering has been filed with the SEC and is available on the SEC's website located at http://www.sec.gov. A final prospectus supplement reflecting the final terms of the Offering will be filed with the SEC. Copies of the preliminary prospectus supplement and the accompanying prospectus relating to the Offering may be obtained from: Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, NY 10282, by telephone at (866) 471-2526, or by email at Prospectus-ny@ny.email.gs.com; Evercore Group L.L.C., Attention: Equity Capital Markets, 55 East 52nd Street, 35th Floor, New York, NY 10055, by telephone at (888) 474-0200, or email: ecm.prospectus@evercore.com; or UBS Securities LLC, Attn: Prospectus Department, 1285 Avenue of the Americas, New York, NY 10019 or email: ol-prospectus-request@ubs.com.
This press release is for informational purposes only and shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.
About Life360
Life360, a family connection and safety company, keeps people close to the ones they love. The category-leading mobile app and Tile tracking devices empower members to stay connected to the people, pets, and things they care about most, with a range of services, including location sharing, safe driver reports, and crash detection with emergency dispatch. As a remote-first company based in the San Francisco Bay Area, Life360 serves approximately 66 million monthly active users (MAU), as of March 31, 2024, across more than 150 countries. Life360 delivers peace of mind and enhances everyday family life in all the moments that matter, big and small. For more information, please visit life360.com.
Life360's CDIs are issued in reliance on the exemption from registration contained in Regulation S of the US Securities Act of 1933, as amended ("Securities Act") for offers of securities which are made outside the US. Accordingly, the CDIs, have not been, and will not be, registered under the Securities Act or the laws of any state or other jurisdiction in the US. As a result of relying on the Regulation S exemption, the CDIs are 'restricted securities' under Rule 144 of the Securities Act. This means that you are unable to sell the CDIs into the US or to a US person who is not a QIB for the foreseeable future except in very limited circumstances until after the end of the restricted period, unless the re-sale of the CDIs is registered under the Securities Act or an exemption is available. To enforce the above transfer restrictions, all CDIs issued bear a FOR Financial Product designation on the ASX. This designation restricts any CDIs from being sold on ASX to US persons excluding QIBs. However, you are still able to freely transfer your CDIs on ASX to any person other than a US person who is not a QIB. In addition, hedging transactions with regard to the CDIs may only be conducted in accordance with the Securities Act.
Forward-looking statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Life360 intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements regarding Life360's intentions, objectives, plans, expectations, assumptions and beliefs about future events, including statements regarding Life360's expectations relating to the commencement of trading of its common stock on the Nasdaq Global Select Market; and the underwriters' 30-day option to purchase additional shares. The words "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," "intend," "may," "might," "plan," "possible," "potential," "predict," "seek," "should," "will," "would" and other similar expressions can generally be used to identify forward-looking statements. Indications of, and guidance or outlook on, future earnings or financial position or performance are also forward-looking statements. Investors and prospective investors are cautioned not to place undue reliance on these forward-looking statements as they involve inherent risk and uncertainty (both general and specific) and should note that they are provided as a general guide only and should not be relied on as an indication or guarantee of future performance. There is a risk that such predictions, forecasts, projections and other forward-looking statements will not be achieved. Subject to any continuing obligations under applicable law, Life360 does not undertake any obligation to publicly release the result of any revisions to these forward-looking statements to reflect events or circumstances after the date of this announcement, to reflect any change in expectations in relation to any forward-looking statements or any change in events, conditions or circumstances on which any such statements are based.
Although Life360 believes that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, Life360 can give no assurance that such expectations and assumptions will prove to be correct and, actual results may vary in a materially positive or negative manner. Forward-looking statements are subject to known and unknown risks, uncertainty, assumptions and contingencies, many of which are outside Life360's control, and are based on estimates and assumptions that are subject to change and may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements. Factors that could cause actual results to differ materially from those in the forward-looking statements include risks related to Life360's business, market risks, Life360's need for additional capital, and the risk that Life360's products and services may not perform as expected, as described in greater detail under the heading "Risk Factors" in Life360's ASX and SEC filings, including its Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 29, 2024 and other reports filed with the SEC. To the maximum extent permitted by law, responsibility for the accuracy or completeness of any forward-looking statements whether as a result of new information, future events or results or otherwise is disclaimed. This announcement should not be relied upon as a recommendation or forecast by Life360. Nothing contained in this document nor any information made available to you is, or shall be relied upon as, a promise, representation, warranty or guarantee as to the past, present or the future performance of Life360.
View original content to download multimedia:https://www.prnewswire.com/news-releases/life360-announces-pricing-of-us-initial-public-offering-302165816.html
SOURCE Life360
FAQ
What is the IPO price for Life360's U.S. offering?
When will Life360's shares start trading on Nasdaq?
How many shares is Life360 offering in its IPO?
What is the ticker symbol for Life360 on Nasdaq?
Will Life360 receive proceeds from the shares sold by selling securityholders?
What will Life360 use the net proceeds from the IPO for?
Are Life360's shares listed on any other exchange?
Who are the underwriters for Life360's IPO?
What is the potential additional share option for Life360's underwriters?
When is the closing date for Life360's IPO?
